Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Urogenital Neoplasms × Pluvicto × Clear all

Phase

Status

Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urogenital Neoplasms 1 Prostatic Neoplasms 1 Prostatic Diseases 1 Neoplasms by Site 1 Neoplasms 1 Genital Neoplasms, Male 1

Interventions

anlotinib 2 tislelizumab 1 onapristone 1 olaparib 1 abiraterone 1 Technetium Tc 99m Medronate 1 Pluvicto 1 Nivolumab 1 Ipilimumab 1 Gemcitabine 1 Gamma Cameras 1 Dosage Forms 1 Diffusion 1 Cisplatin 1 Carboplatin 1 Biopsy, Needle 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05150236 2023-12-15

ANZUP2001

Australian and New Zealand Urogenital and Prostate Cancer Trials Group

Phase 2 Unknown

Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡